Live Quote · NASDAQNTLAHealthcare· Biotechnology

Intellia Therapeutics, Inc.

$10.00▲ 5.04%(+$0.48)
MKT CAP $1.40BNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
59/100
▌ Mixed
47
Valuation
40
Profitability
95
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NTLA research report →

Analyst Price Target
$18.17+81.7% vs. today

Range $8 – $30

Analyst RatingBuy
29 Buy7 Hold3 Sell

Price Chart

+24.38% · this period
$17.84$12.94$8.04Nov 20May 26Nov 20
52-Week Range19% of range
Low
$7.95
Current
$10.00
High
$18.48